These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Patient with high-grade fever, night sweats, and hepatosplenomegaly. Müldür E; Chott A; Mirzaei S; Zojer N; Ludwig H J Clin Oncol; 2011 Apr; 29(10):e254-6. PubMed ID: 21220615 [No Abstract] [Full Text] [Related]
5. Primary cutaneous intravascular large B-cell lymphoma treated with combination chemotherapy and complicated by rituximab-induced interstitial lung disease. Park GH; Kim CH; Chung WK; Won CH; Chang SE; Lee MW; Choi JH; Moon KC Acta Derm Venereol; 2010 May; 90(3):296-8. PubMed ID: 20526551 [No Abstract] [Full Text] [Related]
6. Front-line management of diffuse large B cell lymphoma. Cabanillas F Curr Opin Oncol; 2010 Nov; 22(6):642-5. PubMed ID: 20811278 [TBL] [Abstract][Full Text] [Related]
7. An 82-year-old woman with left upper lobe atelectasis. Diffuse large B-cell lymphoma. Seeram V; Shujaat A; Jones L; Bajwa A Chest; 2012 Dec; 142(6):1669-1674. PubMed ID: 23208341 [No Abstract] [Full Text] [Related]
8. [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report]. Hashimoto A; Fujimi A; Kanisawa Y; Matsuno T; Okuda T; Minami S; Doi T; Ishikawa K; Uemura N; Jyomen Y; Tomaru U Gan To Kagaku Ryoho; 2013 Dec; 40(13):2589-92. PubMed ID: 24335377 [TBL] [Abstract][Full Text] [Related]
9. An unresectable Klatskin's tumor? Hartl J; Werner T; Schramm C Gastroenterology; 2014 Jun; 146(7):e3-4. PubMed ID: 24780210 [No Abstract] [Full Text] [Related]
10. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma. Fabbri A; Gozzetti A; Rigacci L Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541 [No Abstract] [Full Text] [Related]
11. Addictive response of primary cutaneous diffuse large B cell lymphoma leg type to low-dose ibrutinib. Pang A; Au-Yeung R; Leung RYY; Kwong YL Ann Hematol; 2019 Oct; 98(10):2433-2436. PubMed ID: 31446456 [No Abstract] [Full Text] [Related]
12. Two cases of concomitant diffuse large B-cell lymphoma and myelodysplastic syndrome. Dozzo M; Zaja F; Volpetti S; Chiozzotto M; Puglisi S; Mazzucco M; Perali G; Fanin R Am J Hematol; 2014 Oct; 89(10):1011-3. PubMed ID: 24912474 [No Abstract] [Full Text] [Related]
13. Clinical features and treatment outcomes of intravascular large B-cell lymphoma: a single-center experience in Korea. Hong JY; Kim HJ; Ko YH; Choi JY; Jung CW; Kim SJ; Kim WS Acta Haematol; 2014; 131(1):18-27. PubMed ID: 24021554 [TBL] [Abstract][Full Text] [Related]
14. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma. Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528 [TBL] [Abstract][Full Text] [Related]
15. Diffuse large B-cell lymphoma with a bulky mass in the cranial vault. Kanaya M; Endo T; Hashimoto D; Endo S; Takemura R; Okada K; Hatanaka KC; Matsuno Y; Teshima T Int J Hematol; 2017 Aug; 106(2):147-148. PubMed ID: 28390034 [No Abstract] [Full Text] [Related]
16. [Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma]. Yi SH; Xu Y; Zou DH; An G; Zhao YZ; Qi JY; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):307-12. PubMed ID: 19799125 [TBL] [Abstract][Full Text] [Related]
17. Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma. Cho H; Yoon DH; Kim JH; Ko YB; Kwon BS; Song IH; Suh C Korean J Intern Med; 2016 May; 31(3):605-7. PubMed ID: 26968186 [No Abstract] [Full Text] [Related]
19. Rituximab CHOP for successful management of diffuse large B-cell lymphoma of the ovary. Ahbeddou N; Fetohi M; Khanoussi BE; Errihani H Arch Gynecol Obstet; 2011 May; 283(5):1173-4. PubMed ID: 20957380 [No Abstract] [Full Text] [Related]
20. [Interest of an intensive chemotherapy for intravascular large B cell lymphoma]. Baldolli A; Chuffart M; Geffray L; Verneuil L; Reman O Bull Cancer; 2013 Apr; 100(4):317-21. PubMed ID: 23587663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]